Appleyard Lees


Genetics has come a long way since Watson and Crick published their paper in Nature in 1953 on the structure of DNA.

We have experts in this area who not only have degrees in genetics, but have served time in laboratories, cloning and using recombinant DNA techniques. Our attorneys have in depth experience in patents in the field of genetics, including protecting gene/peptide sequences, genetic screening assays, nucleotide conjugates, pharmacogenetics, gene chip arrays, plant genetics and transgenic organisms. Patents directed towards genetic inventions have their own requirements and we know when and how to submit electronic gene sequences and when to deposit vectors or organisms to ensure that valid patent applications are filed.

The goal posts for what is patentable in the area of genetics keep on moving. For example, the question of whether a gene sequence is patentable is one which Courts around the world have frequently been required to consider, against a backdrop of concern that patents are being used to protect little more than naturally occurring elements of a human body. Appleyard Lees’ Life Sciences attorneys are quick to respond and always keep in mind both decided case law and issues as yet undecided (whether in Europe or further afield), when advising clients and preparing patent applications. In this way we have the right strategy in place so that if the law changes, we continue to maximise your patent position and minimise your risk.